Results 101 to 110 of about 3,650 (207)

The effect of medroxyprogesterone acetate and heparin in the prevention of postsurgical adhesion formation in the rat uterine model

, 1999
Objective: To evaluate the effects of depot medroxyprogesterone acetate and heparin in preventing postsurgical adhesion formation in the rat model. Methods: A hundred and five female Wistar rats were divided into 7 groups.
Özşener S., Yilmaz H., Sagol S., Karadadas N., Dinçer O.   +4 more
core   +1 more source

Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. [PDF]

Curr HIV/AIDS Rep, 2023
Dabee S, Balle C, Onono M, Innes S, Nair G, Palanee-Phillips T, Burgener AD, Bosinger SE, Passmore JS, Heffron R, Jaspan H, Happel AU.   +11 more
europepmc   +1 more source

Case Report: Development of persistent genital arousal disorder due to a possible combination of medications

Frontiers in Psychiatry
ObjectivePersistent Genital Arousal Disorder (PGAD) is a rare and distressing condition characterized by persistent genital arousal in the absence of sexual desire.
Ludek Fiala, Ludek Fiala, Jiří Lenz, Jiří Lenz   +3 more
doaj   +1 more source

Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use

, 2008
UnlabelledThis study assessed associations between habitual caffeine intake and bone mass among young women. Analyses of the entire study population revealed no significant associations, while analyses restricted to women using depot medroxyprogesterone ...
Ott, SM, Scholes, D, Wetmore, CM, Ichikawa, L, LaCroix, AZ   +4 more
core   +1 more source

Efficacy and patient satisfaction with Sayana Press (DMPA-SC) among women seeking birth spacing

Journal of the Pakistan Medical Association
Objectives: To determine the efficacy of depot medroxyprogesterone acetate subcutaneous injection in females seeking birth-spacing, and to evaluate patient satisfaction. Method: The descriptive case series was conducted at the Department of Obstetrics
Saman Asghar, Anam Riaz, Saher Riaz, Hafiza Iqra Iqbal, Saba Rasool, Shysta Shaukat   +5 more
doaj   +1 more source

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]

PLOS Glob Public Health, 2023
Porter Erlank C, Ali G, Birhanu F, Stanley M, Chirwa JS, Kachale F, Gunda A.   +6 more
europepmc   +1 more source

Depot Medroxyprogesterone Acetate: Safety and Efficacy Update

Clinical Medicine Reviews in Women's Health, 2010
Depot medroxyprogesterone acetate (DMPA) is a long-acting, reversible progestin-only contraceptive method that is administered either intramuscularly or subcutaneously every 12 weeks. Because of its high efficacy, ease of use, privacy, and non-contraceptive benefits, adolescent and adult women are increasingly utilizing DMPA as their contraceptive ...
openaire   +1 more source

Pregnancies Associated With Sperm Concentrations Below 10 Million/ml In Clinical Studies Of A Potential Male Contraceptive Method, Monthly Depot Medroxyprogesterone Acetate And Testosterone Esters

, 2015
A potential male contraceptive approach was evaluated in clinical trials involving monthly injections of depot medroxyprogesterone acetate and either subdermal implants of testosterone propionate or monthly injections of testosterone enanthate ...
Coutinho E., Barfield A., Alvarez-Sanchez F., Bartsch G., Leon P., Weiske W.-H., Faundes A., Bernstein G., Frick J., Melo J., Brache V., Brenner P., Mishell Jr. D., Ortiz A.   +13 more
core   +1 more source

Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19. [PDF]

Contraception, 2023
Smith TJ, Urdanigo TK, Shroff N, Rubin SE.   +3 more
europepmc   +1 more source

Forearm Bone Density In Long-term Users Of Oral Combined Contraceptives And Depot Medroxyprogesterone Acetate.

, 2015
To compare the bone mineral density of users of combined oral contraceptives (OC) or depot medroxyprogesterone acetate (depot-MPA) with women who have never used a hormonal contraceptive method. Cross-sectional study. Academic tertiary-care hospital.
Castro, S, Perrotti, M, Bahamondes, L, Petta, C   +3 more
core